Latest News
Using TMS to Reveal Neurophysiological Biomarkers in Parkinson’s Disease
The Science Behind to Attend Anglonordic Life Science Conference 2026
The Underrepresentation of Women in CNS Clinical Trials
Webinar - Using Transcranial Magnetic Stimulation to Probe Inhibitory Activity in Patients and Healthy Controls
From Setback to Strategy: Rethinking Cognitive Schizophrenia Trials - Why the CONNEX Trials Failed
Design-Driven Foresight in CNS Drug Development: Bridging the Valley of Death
Advances in CNS Trials: Key 2025 Milestones and 2026 Outlook
Harnessing Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome
Webinar - Probing Sodium Channel Blockers In Vivo: TMS Strength–Duration Metrics as a Translational Biomarker
Pain and Quantitative Sensory Testing in Clinical Trials: Why it Matters for CNS Drug Development
Alzheimer's Disease in Clinical Trials
How TMS is Reshaping Clinical Research